Previous 10 | Next 10 |
Gainers: Lee Enterprises (NYSE: LEE ) +85% . More news on: Lee Enterprises, Incorporated, Roadrunner Transportation Systems, Inc., Hepion Pharmaceuticals, Inc., Stocks on the move, , Read more ...
Sintx Technologies (NASDAQ: SINT ) -25% . More news on: Sintx Technologies, Inc., Martin Midstream Partners L.P., Spring Bank Pharmaceuticals, Inc., , Stocks on the move, Read more ...
Continuing to focus on immuno-oncology & inflammation, including IV STING agonist clinical program, oral STING antagonist platform and STING agonist ADCs Adjusting cost structure to fund operations into late 2022 HOPKINTON, Mass., Jan. 29, 2020 (GLOBE NEWSWIRE) -- Spring Ba...
Gainers: Neovasc (NASDAQ: NVCN ) +70% . More news on: Neovasc Inc., Inpixon, FuelCell Energy, Inc., Stocks on the move, Read more ...
Pintec Technology Holdings (NASDAQ: PT ) +97% on agreement with China Unicom to expand handset financing. More news on: Pintec Technology Holdings Limited, FuelCell Energy, Inc., Flexion Therapeutics, Inc., Stocks on the move, Read more ...
Gainers: China Rapid Finance (NYSE: XRF ) +142% . More news on: China Rapid Finance Limited, Liquidia Technologies, Inc., NewLink Genetics Corporation, Stocks on the move, Read more ...
Spectrum Pharmaceuticals (NASDAQ: SPPI ) -54% after poziotinib misses endpoing. More news on: Spectrum Pharmaceuticals, Inc., Spring Bank Pharmaceuticals, Inc., QIAGEN N.V., Stocks on the move, Read more ...
Spring Bank Pharmaceuticals (NASDAQ: SBPH ) stops dosing and enrolling patients in its Phase 2b Catalyst trials, which are examining the use of inarigivir soproxil 400mg for the treatment of chronic hepatitis B virus, after observing symptoms consistent with liver injury in...
HOPKINTON, Mass., Dec. 26, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced that the company h...
HOPKINTON, Mass., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced two hepatitis B vi...
News, Short Squeeze, Breakout and More Instantly...
Spring Bank Company Name:
SBPH Stock Symbol:
NASDAQ Market:
F-star Therapeutics Completes Combination with Spring Bank Pharmaceuticals To Commence Trading November 23 on Nasdaq: FSTX PR Newswire CAMBRIDGE, England and CAMBRIDGE, Mass., Nov. 20, 2020 CAMBRIDGE, England and CAMBRIDGE, Mass. , Nov. 20, 2020 /PRN...
CORRECTING and REPLACING Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics 1-for-4 Reverse Stock Split to be Effective November 23, 2020 PR Newswire HOPKINTON, Mass., Nov. 20, 2020 HOPKINTON, Mass. , Nov. 20, 2020 /PRNe...
HOPKINTON, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) (“Spring Bank”), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, announced that at its special meeting of stock...